Walleye Trading LLC Biogen Inc. Call Options Transaction History

Walleye Trading LLC

$41.2 Billion
Q2 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $3.07 Million - $3.81 Million	-16,100 Reduced 56.29%	12,500 $2.9 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $869,282 - $1.1 Million	4,100 Added 16.73%	28,600 $6.17 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $1.62 Million - $1.96 Million	7,300 Added 42.44%	24,500 $6.34 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $886,550 - $1 Million	-3,500 Reduced 16.91%	17,200 $4.42 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $4.93 Million - $5.69 Million	-17,900 Reduced 46.37%	20,700 $5.9 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $10.7 Million - $12.2 Million	-41,900 Reduced 52.05%	38,600 $10.7 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $4.39 Million - $5.34 Million	-17,400 Reduced 17.77%	80,500 $22.3 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $4.93 Million - $6.79 Million	25,300 Added 34.85%	97,900 $26.1 Million
Q2 2022 Aug 08, 2022	BUY	$187.54 - $223.02 $9.83 Million - $11.7 Million	52,400 Added 259.41%	72,600 $14.8 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $2.85 Million - $3.59 Million	-14,700 Reduced 42.12%	20,200 $4.25 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $5.22 Million - $6.71 Million	23,300 Added 200.86%	34,900 $8.37 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $2.35 Million - $3.06 Million	8,300 Added 251.52%	11,600 $3.28 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $1.24 Million - $1.99 Million	-4,800 Reduced 59.26%	3,300 $1.14 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $4.88 Million - $5.72 Million	-20,100 Reduced 71.28%	8,100 $2.27 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $6 Million - $9.03 Million	-25,400 Reduced 47.39%	28,200 $6.91 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $8.21 Million - $9.48 Million	31,000 Added 137.17%	53,600 $15.2 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $620,784 - $822,120	-2,400 Reduced 9.6%	22,600 $6.05 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $752,780 - $954,912	-2,800 Reduced 10.07%	25,000 $7.91 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $4.51 Million - $6.23 Million	20,500 Added 280.82%	27,800 $8.25 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $2.98 Million - $3.34 Million	-13,700 Reduced 65.24%	7,300 $1.7 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $4.43 Million - $4.88 Million	20,200 Added 2525.0%	21,000 $4.91 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $2.47 Million - $3.86 Million	-11,400 Reduced 93.44%	800 $189,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $891,200 - $1.13 Million	3,200 Added 35.56%	12,200 $3.67 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $5.17 Million - $6.76 Million	-17,600 Reduced 66.17%	9,000 $3.18 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $669,552 - $797,966	-2,600 Reduced 8.9%	26,600 $7.72 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $2.84 Million - $4.01 Million	10,900 Added 59.56%	29,200 $8 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $399,932 - $447,954	-1,300 Reduced 6.63%	18,300 $5.83 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $393,609 - $461,566	-1,400 Reduced 6.67%	19,600 $6.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,000	21,000 $5.7 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account